Last reviewed · How we verify

Magnesium Threonate

University of Miami · FDA-approved active Small molecule Quality 5/100

Magnesium Threonate is a Small molecule drug developed by University of Miami. It is currently FDA-approved.

At a glance

Generic nameMagnesium Threonate
SponsorUniversity of Miami
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Magnesium Threonate

What is Magnesium Threonate?

Magnesium Threonate is a Small molecule drug developed by University of Miami.

Who makes Magnesium Threonate?

Magnesium Threonate is developed and marketed by University of Miami (see full University of Miami pipeline at /company/university-of-miami).

What development phase is Magnesium Threonate in?

Magnesium Threonate is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing